Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
MAUI, Hawaii, Oct. 16 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (OTC: BPYT) ("Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has engaged Active Sales and Marketing of Southern California as its Master Distributor covering the Western United States, including the states of California, Washington, Nevada, Arizona, Colorado, Utah, Idaho, New Mexico and Oregon.
The agreement will initially distribute six of Bioponic's most popular health and well-being products: Hawaiian Healing Mist(TM); O-Spray(TM); Throat Note(TM); Traveler's 1st Aid(TM); Noni Healing Tonic and Ginzeng! Descriptions of these products can be found at http://www.bioponic.com.
According to the Natural Foods Merchandiser, in 2006, retail channels accounted for 81%, or $46.1 billion, of total natural product sales in the U.S. Steven M. Schorr, Chairman & CEO of Bioponic, said, "With this agreement, we mark a significant new milestone in carving out an all-important U.S. retail presence beyond the local Hawaiian market."
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray(R) (http://www.flightspray.com), O-Spray(TM), Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being. For more information, visit www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, firstname.lastname@example.org or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, email@example.com, www.otcfn.com/bpyt.